This is the place for the latest information about our work here at Glaucoma Research Foundation and for current events in the world of eye health. All breakthroughs and insights are made possible through the dedication of researchers, and through the continued financial support and active involvement of the community.

Glaucoma and Your Emotional Well-Being

If you have glaucoma, you may be experiencing emotional challenges in addition to the impact of glaucoma on your vision.

Million Dollar Eyes: Bianca Beach’s Glaucoma Story

“I’ve shifted perspective on my eye health. I took something that used to be a negative and turned it in to a positive.”

Alternative Drug Delivery Systems for Glaucoma: A Dropless Future?

Currently, there is extensive research and development on “drop-free” or “drop-less” technologies for delivering glaucoma medications to the eye.

What Eye Pressure is Safe for Me?

The short answer is that “it’s complicated!” This Q&A addresses some common questions.

African Descent and Glaucoma: Unraveling the Genetics Putting a Community at Higher Risk

Glaucoma occurs about five times more often in African Americans and blindness from glaucoma is about six times more common. In addition to this higher frequency, glaucoma often occurs earlier in life.

Glaucoma: Family Inheritance?

Several risk factors can increase a person’s risk of developing hereditary glaucoma.

January is Glaucoma Awareness Month

January is National Glaucoma Awareness Month, an important time to spread the word about this sight-stealing disease.

Is There a Safe Stem-cell Treatment for Glaucoma in 2023?

Jeffrey Goldberg, MD, PhD reviews recent research progress and explains the potential risks.

Update from the Catalyst for a Cure Vision Restoration Initiative

The Catalyst for a Cure Vision Restoration team has identified a set of three genes that, when inhibited, improve the survival of optic nerve cells in models of glaucoma.

Smart Contact Lenses Offer Exciting Glaucoma Breakthrough

Smart contact lenses use tiny sensors to collect data about the pressure inside your eye. They can measure and monitor changes in IOP, or provide on-demand release of glaucoma medication.

The 2022 Weston Lecture: Ahmara Gibbons Ross, MD, PhD

“Neuroprotection: A New Path for Glaucoma Patients” was the topic of the 2022 Weston Family Lecture presented virtually on October 27, 2022.

The What, Why, When, and How of Planned Giving

This one-hour recorded webinar was first presented on October 14, 2022 by Glaucoma Research Foundation.

The Power of Connection: Peer Support for Glaucoma Patients and Their Loved Ones

Whether you’ve recently been diagnosed with glaucoma or are learning how to cope, connecting with others can be helpful and powerful.

Assistive Technology

Assistive devices and technology can help people with low vision and vision loss to participate in daily activities with minimal impairment.

Tips To Help a Child With Glaucoma in the Classroom

If your child has glaucoma or a child in your classroom has it, you may wonder how the condition affects their ability to learn in school.

Can Glaucoma Affect Contrast Sensitivity?

Contrast sensitivity is the eyes’ ability to identify an object not clearly defined from its background.

Santen Receives FDA Approval for Omlonti for Primary Open-Angle Glaucoma

The new glaucoma eye drop medication increases drainage through the eye’s conventional outflow pathways via a unique pharmacological action.

Can Diet Affect Glaucoma?

Although no studies prove a connection between specific foods and glaucoma, it’s safe to assume that your diet and your overall health can affect the disease.

Tips To Minimize the Side Effects of Glaucoma Medications

If you are experiencing side effects from your glaucoma medications, learn what you can do to reduce or eliminate them.

Neurodegeneration Explained

What is neurodegeneration? And how will discoveries related to it affect people with glaucoma?

Catalyst for a Cure: Meet the New Team of Investigators

The Catalyst for a Cure Initiative to Prevent and Cure Neurodegeneration.

Fourth Catalyst for a Cure Tackles Neurodegeneration

Made possible by visionary donors, Glaucoma Research Foundation’s latest research initiative targets the shared roots of conditions that occur when neurons deteriorate and die.

Meet Renaissance Innovators Ted and Melza Barr

The Catalyst for a Cure Initiative to Prevent and Cure Neurodegeneration is the inspiration of longtime GRF supporters Ted and Melza Barr.

Catalyst for a Cure: A Synergistic Approach to Scientific Research

Dr. John G. Flanagan discusses recent discoveries that could cure glaucoma based on key research accomplishments from 20 years of Catalyst for a Cure.

Study: Black Glaucoma Patients Six Times More Likely to Have Advanced Vision Loss than White Patients

A study by US researchers compared levels of sight loss in patients with a new diagnosis of primary open-angle glaucoma.